Yahoo
NYSEArca - Nasdaq Real Time Price USD

Invesco S&P 500 Low Volatility ETF (SPLV)

74.66 +0.12 (+0.16%)
At close: September 2 at 4:00:00 PM EDT
74.58 -0.08 (-0.11%)
After hours: September 2 at 7:45:34 PM EDT
Trade SPLV on Coinbase
Chart Range Bar
Loading chart for SPLV
Chart does not reflect overnight price.
  • Previous Close 74.54
  • Open 74.58
  • Bid 74.57 x 520000
  • Ask 74.78 x 850000
  • Day's Range 74.26 - 74.87
  • 52 Week Range 69.63 - 78.82
  • Volume 2,681,766
  • Avg. Volume 2,348,030
  • Net Assets 7.25B
  • NAV 74.65
  • PE Ratio (TTM) 20.57
  • Yield 2.12%
  • YTD Daily Total Return 6.14%
  • Beta (5Y Monthly) 0.36
  • Expense Ratio (net) 0.25%

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.

Invesco

Fund Family

Large Value

Fund Category

7.25B

Net Assets

2011-05-05

Inception Date

Performance Overview

View More

Trailing returns as of 8/31/2026. Category is Large Value.

YTD Return

SPLV
6.14%
Category
7.82%

1-Year Return

SPLV
3.90%
Category
26.16%

3-Year Return

SPLV
9.13%
Category
15.87%

People Also Watch

Holdings

View More

Top 10 Holdings (12.50% of Total Assets)

Symbol Company % Assets
Loews Corporation 1.37%
FirstEnergy Corp. 1.32%
Berkshire Hathaway Inc. 1.31%
Johnson & Johnson 1.25%
The Coca-Cola Company 1.24%
The Travelers Companies, Inc. 1.23%
Duke Energy Corporation 1.21%
Ameren Corporation 1.20%
Cintas Corporation 1.19%
Realty Income Corporation 1.18%

Sector Weightings

Research Reports

View More
  • ASML Earnings: While the New 2026 Outlook Is No Big Surprise, Long-Term Prospects Vastly Improved

    ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s largest clients are TSMC, Samsung, Intel, SK Hynix, and Micron.

    Rating
    Price Target
  • Raising target price to $69.00

    REALTY INCOME CORP has an Investment Rating of BUY; a target price of $69.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
  • ASML Earnings: While the New 2026 Outlook Is No Big Surprise, Long-Term Prospects Vastly Improved

    ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s largest clients are TSMC, Samsung, Intel, SK Hynix, and Micron.

    Rating
    Price Target
  • Management lowers guidance, near-term upside seems limited

    Biogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. The company is the market leader in MS drugs and launched the first approved treatments for spinal muscular atrophy and AD. The company also sells products that treat plaque psoriasis, non-Hodgkin's lymphoma, lymphocytic leukemia, and rheumatoid arthritis. Current research continues on MS and has expanded to include neuroimmunology, ophthalmology, lupus, and other neuromuscular and movement disorders. Founded in 1978, the company is located in Cambridge, Massachusetts; employs 7,500 people; and is a component of the S&P 500.

    Rating
    Price Target

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: